US Stock MarketDetailed Quotes
HOOK HOOKIPA Pharma
- 4.880
- +0.110+2.31%
Close Aug 15 16:00 ET
48.29MMarket Cap-1184P/E (TTM)
5.010High4.740Low33.78KVolume4.760Open4.770Pre Close164.67KTurnover0.73%Turnover RatioLossP/E (Static)9.89MShares11.30052wk High0.56P/B22.56MFloat Cap4.10052wk Low--Dividend TTM4.62MShs Float200.000Historical High--Div YieldTTM5.66%Amplitude4.100Historical Low4.874Avg Price1Lot Size
About HOOKIPA Pharma Company
HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.
Company Profile
SymbolHOOK
Company NameHOOKIPA Pharma
Listing DateApr 18, 2019
Issue Price14.00
Founded2011
CEODr. Malte Peters, M.D.
MarketNASDAQ
Employees179
Fiscal Year Ends12-31
Address350 Fifth Avenue,72nd floor, Suite 7240
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10118
Phone43-1-890-6360
Websitehttp://www.hookipapharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Malte Peters, M.D.
- Director, Chief Executive Officer and President
- 232.31K
- Klaus Orlinger
- Chief Scientific Officer
- --
- Terry Coelho
- Director, Executive Vice President, Principal Accounting Officer and Chief Financial Officer
- 85.88K
- Mark Winderlich
- Chief Development Officer
- --
- Roman Necina
- Chief Operations Officer
- --
- Dr. Jan G. J. van de Winkel, PhD
- Chairman of the Board
- 127.98K
- Dr. Timothy P. Reilly, PhD
- Director
- 71.74K
- David Ross Kaufman
- Independent Director
- 71.74K
- Sean A. Cassidy
- Independent Director
- --
- Julie O'Neill
- Independent Director
- 67.74K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg